Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20261018071471N1Phase 3Completed
Phase 3, randomised, open-label trial of opium tincture and methadone in opioid use disorder (OUD) (4 arms), sponsored by Islamic Azad University. Primary endpoints: Treatment readiness, Sexual functioning and 1 more. Started Jan 2026; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20261018071471N1.